Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 49.80
-1.60 (-3.11%)
At close: Jan 16, 2026
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €797.4 million as of January 16, 2026. Its market cap has increased by 52.07% in one year.
Market Cap
797.40M
Enterprise Value
821.08M
Revenue
296.76M
Ranking
n/a
PE Ratio
19.70
Stock Price
€49.80
Market Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 797.40M, an increase of 115.79%. That is a compound annual growth rate of 4.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 797.40M | 0.20% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.58B |
| Laboratorios Farmaceuticos Rovi | 3.58B |
| Almirall | 2.84B |
| Faes Farma | 1.59B |
| Pharma Mar | 1.39B |
| Oryzon Genomics | 249.96M |
| Atrys Health | 232.18M |
| Prim, S.A. | 224.61M |